Skip to main content

CHANGE OF DATE - Seminar: Surgical OPTOMICS & Robotics: the precision pathway, Prof Michele Diana, University of Strasbourg

Date
Date
Tuesday 26 March 2024, 1400 - 1500
Location
Rhodes LT, Elec Eng.

Bio

Prof. Michele Diana, MD, Ph.D, EMBA, obtained the Medical Degree in Rome, Italy, and specialized in General Surgery in Switzerland. He obtained a Ph.D in Medical Sciences and received the Venia Legendi at the University of Strasbourg (France). Additionally, he holds an Executive Master in Business Administration from INSEAD Business School. He is faculty member of leading scholar surgical societies, including the SAGES, the European Association of Endoscopic Surgery (EAES), the International Society of Fluorescence Guided Surgery (ISFGS) and the International Society of Medical Innovation and Technology (iSMIT). His main translational research interests include image-guided surgery, surgical robotics and surgical applications of machine and deep learning. He has authored more than 250 peer-reviewed papers and book chapters (h-index 45).

Current position(s) & affiliations:

  • Scientific Director, IRCAD, Research Institute against Digestive Cancer, Strasbourg, France
  • Staff Surgeon, University Hospital of Strasbourg, France
  • Permanent Researcher, ICube Lab, Photonics for Health, Strasbourg, France
  • Founder and Chief Medical Officer @ ASTRANICE, Strasbourg, France

Google scholar profile: https://scholar.google.fr/citations?user=1HYUb68AAAAJ&hl=fr

LinkedIn profile: https://www.linkedin.com/in/michele-diana-b972382a/

Abstract

Intraoperative optical technologies such as Near-Infrared Fluorescence imaging, multispectral or hyperspectral imaging enable an improved visualization of unapparent anatomical structures, the evaluation of metabolic activities and the enhanced visualization of tumor tissue, when compared to white light evaluation alone. Thanks to some groundbreaking innovations, optical imaging can well be a powerful theranostic tool that can help tackling the challenges of surgical oncology: to ensure a complete removal of tumor tissue and to reduce the risk of surgical complications.

An extensive intelligence and networking activity, including main opinion leaders in the field, has allowed identifying 4 major axes of development of optical imaging, including:

1) SOFTWARE: the integration of computer-assisted interpretation of the optically generated signal through dedicated software solution and Artificial Intelligence, machine and deep learning approaches, towards the building of an OPTOMICS paradigm, in analogy with other omics (genomics, proteomics, metabolomics, radiomics).

2) HARDWARE: the development of improved hardware solutions, with optimized sensitivity and improved ergonomics.

3) CHEMISTRY: the development of innovative probes, which recognize precisely biological targets or tumor cells and allow for image-guided removal of cancers by focused energy delivery or surgical ablation.